Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Gordi, Toufigh
Xie, Rujia
and
Jusko, William J.
2005.
Semi‐mechanistic pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of artemisinin.
British Journal of Clinical Pharmacology,
Vol. 60,
Issue. 6,
p.
594.
Czock, David
and
Keller, Frieder
2007.
Mechanism-based pharmacokinetic–pharmacodynamic modeling of antimicrobial drug effects.
Journal of Pharmacokinetics and Pharmacodynamics,
Vol. 34,
Issue. 6,
p.
727.
CROOKS, L.
2008.
Problems with continuous-time malaria models in describing gametocytogenesis.
Parasitology,
Vol. 135,
Issue. 8,
p.
881.
Czock, David
Markert, Christoph
Hartman, Bertram
and
Keller, Frieder
2009.
Pharmacokinetics and pharmacodynamics of antimicrobial drugs.
Expert Opinion on Drug Metabolism & Toxicology,
Vol. 5,
Issue. 5,
p.
475.
Winter, Katherine
and
Hastings, Ian M.
2011.
Development, Evaluation, and Application of an
In Silico
Model for Antimalarial Drug Treatment and Failure
.
Antimicrobial Agents and Chemotherapy,
Vol. 55,
Issue. 7,
p.
3380.
Saralamba, Sompob
Pan-Ngum, Wirichada
Maude, Richard J.
Lee, Sue J.
Tarning, Joel
Lindegårdh, Niklas
Chotivanich, Kesinee
Nosten, François
Day, Nicholas P. J.
Socheat, Duong
White, Nicholas J.
Dondorp, Arjen M.
and
White, Lisa J.
2011.
Intrahost modeling of artemisinin resistance in
Plasmodium falciparum
.
Proceedings of the National Academy of Sciences,
Vol. 108,
Issue. 1,
p.
397.
Zaloumis, Sophie
Humberstone, Andrew
Charman, Susan A
Price, Ric N
Moehrle, Joerg
Gamo-Benito, Javier
McCaw, James
Jamsen, Kris M
Smith, Katherine
and
Simpson, Julie A
2012.
Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development.
Malaria Journal,
Vol. 11,
Issue. 1,
Kay, Katherine
Hastings, Ian M.
and
Ferguson, Neil
2013.
Improving Pharmacokinetic-Pharmacodynamic Modeling to Investigate Anti-Infective Chemotherapy with Application to the Current Generation of Antimalarial Drugs.
PLoS Computational Biology,
Vol. 9,
Issue. 7,
p.
e1003151.
White, Nicholas J.
2013.
Pharmacokinetic and Pharmacodynamic Considerations in Antimalarial Dose Optimization.
Antimicrobial Agents and Chemotherapy,
Vol. 57,
Issue. 12,
p.
5792.
Johnston, Geoffrey L.
Gething, Peter W.
Hay, Simon I.
Smith, David L.
Fidock, David A.
and
Ferguson, Neil M.
2014.
Modeling Within-Host Effects of Drugs on Plasmodium falciparum Transmission and Prospects for Malaria Elimination.
PLoS Computational Biology,
Vol. 10,
Issue. 1,
p.
e1003434.
Hastings, Ian M
and
Hodel, Eva Maria
2014.
Pharmacological considerations in the design of anti-malarial drug combination therapies – is matching half-lives enough?.
Malaria Journal,
Vol. 13,
Issue. 1,
Kay, Katherine
Hodel, Eva Maria
and
Hastings, Ian M.
2014.
Improving the Role and Contribution of Pharmacokinetic Analyses in Antimalarial Drug Clinical Trials.
Antimicrobial Agents and Chemotherapy,
Vol. 58,
Issue. 10,
p.
5643.
Simpson, Julie A.
Zaloumis, Sophie
DeLivera, Alysha M.
Price, Ric N.
and
McCaw, James M
2014.
Making the Most of Clinical Data: Reviewing the Role of Pharmacokinetic-Pharmacodynamic Models of Anti-malarial Drugs.
The AAPS Journal,
Vol. 16,
Issue. 5,
p.
962.
Hodel, Eva Maria
Kay, Katherine
Hayes, Daniel J
Terlouw, Dianne J
and
Hastings, Ian M
2014.
Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling.
Malaria Journal,
Vol. 13,
Issue. 1,
Lakshminarayana, Suresh B.
Freymond, Céline
Fischli, Christoph
Yu, Jing
Weber, Sebastian
Goh, Anne
Yeung, Bryan K. S.
Ho, Paul C.
Dartois, Véronique
Diagana, Thierry T.
Rottmann, Matthias
and
Blasco, Francesca
2015.
Pharmacokinetic-Pharmacodynamic Analysis of Spiroindolone Analogs and KAE609 in a Murine Malaria Model.
Antimicrobial Agents and Chemotherapy,
Vol. 59,
Issue. 2,
p.
1200.
Aljayyoussi, Ghaith
Kay, Katherine
Ward, Stephen A.
and
Biagini, Giancarlo A.
2016.
OptiMal-PK: an internet-based, user-friendly interface for the mathematical-based design of optimized anti-malarial treatment regimens.
Malaria Journal,
Vol. 15,
Issue. 1,
Hastings, Ian M.
Hodel, Eva Maria
and
Kay, Katherine
2016.
Quantifying the pharmacology of antimalarial drug combination therapy.
Scientific Reports,
Vol. 6,
Issue. 1,
Hodel, Eva Maria
Kay, Katherine
and
Hastings, Ian M.
2016.
Incorporating Stage-Specific Drug Action into Pharmacological Modeling of Antimalarial Drug Treatment.
Antimicrobial Agents and Chemotherapy,
Vol. 60,
Issue. 5,
p.
2747.
Cao, Pengxing
Klonis, Nectarios
Zaloumis, Sophie
Dogovski, Con
Xie, Stanley C.
Saralamba, Sompob
White, Lisa J.
Fowkes, Freya J. I.
Tilley, Leann
Simpson, Julie A.
and
McCaw, James M.
2017.
A Dynamic Stress Model Explains the Delayed Drug Effect in Artemisinin Treatment of Plasmodium falciparum.
Antimicrobial Agents and Chemotherapy,
Vol. 61,
Issue. 12,
Ferreira, Michelle V. D.
Vieira, José L. F.
Almeida, Eduardo D.
Rivera, Juan G. B.
Gomes, Margarete S. M.
and
de Siqueira, André M.
2018.
Pharmacokinetics of mefloquine administered with artesunate in patients with uncomplicated falciparum malaria from the Brazilian Amazon basin.
Malaria Journal,
Vol. 17,
Issue. 1,